{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:35:57Z","timestamp":1791293757303,"version":"4.1.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["ESR 14-10649"],"award-info":[{"award-number":["ESR 14-10649"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.2217\/imt-2021-0149","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T10:41:55Z","timestamp":1641379315000},"page":"189-199","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":36,"title":["Peripheral Blood Eosinophil Count is Associated with Response to Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer"],"prefix":"10.1080","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-3996","authenticated-orcid":false,"given":"Hazem","family":"Ghebeh","sequence":"first","affiliation":[{"name":"Research Centre, King Faisal Specialist Hospital&amp;Research Center, Riyadh11211, Saudi Arabia"},{"name":"College of Medicine, Al-Faisal University, Riyadh11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A","family":"Elshenawy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, King Faisal Specialist Hospital&amp;Research Center, Riyadh11211, Saudi Arabia"},{"name":"Department of Clinical Oncology, Menoufia University, Menoufia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adher D","family":"AlSayed","sequence":"additional","affiliation":[{"name":"Research Centre, King Faisal Specialist Hospital&amp;Research Center, Riyadh11211, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Al-Tweigeri","sequence":"additional","affiliation":[{"name":"Research Centre, King Faisal Specialist Hospital&amp;Research Center, Riyadh11211, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"e_1_3_7_3_1","volume-title":"StatPearls.","author":"Kanuru S","year":"2021","unstructured":"Kanuru S , SapraA. Eosinophilia. In: StatPearls.StatPearls Publishing, Treasure Island, FL, USA (2021)."},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1393134"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt027"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3159"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3341"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0108058"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0196"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3861"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98113-6"},{"issue":"2","key":"e_1_3_7_12_1","first-page":"152","article-title":"Association between peripheral eosinophils and clinical outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors","volume":"131","author":"Okauchi S","year":"2021","unstructured":"Okauchi S , ShiozawaT, MiyazakiKet al. Association between peripheral eosinophils and clinical outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. Pol. Arch. Intern. Med.131(2), 152\u2013160 (2021).","journal-title":"Pol. Arch. Intern. Med."},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.918770"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0676"},{"issue":"2","key":"e_1_3_7_15_1","first-page":"1419","article-title":"Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma","volume":"26","author":"Ishibashi S","year":"2006","unstructured":"Ishibashi S , OhashiY, SuzukiTet al. Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. Anticancer Res.26(2B), 1419\u20131424 (2006).","journal-title":"Anticancer Res."},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2412"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.5578\/tt.66667"},{"issue":"6","key":"e_1_3_7_18_1","first-page":"2997","article-title":"Eosinophil infiltration of human colonic carcinomas as a prognostic indicator","volume":"43","author":"Pretlow TP","year":"1983","unstructured":"Pretlow TP , KeithEF, CryarAKet al. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res.43(6), 2997\u20133000 (1983).","journal-title":"Cancer Res."},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0127"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2020-0070"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0138"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40800-018-0078-z"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32829"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0318-0"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1761176"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26120"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1722022"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0743-5"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-43654-4_5"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0186"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-020-00126-6"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0300060515593248"},{"key":"e_1_3_7_33_1","article-title":"BC Cancer Drug Manual","author":"Provincial Health Services Authority.","year":"2021","unstructured":"Provincial Health Services Authority. BC Cancer Drug Manual. Durvalumab.www.bccancer.bc.ca\/drug-database-site\/Drug%20Index\/Durvalumab_monograph.pdf (2021).","journal-title":"Durvalumab."},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235076"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051776"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13311"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.02.015"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00424"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000446"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2021-0149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:22:44Z","timestamp":1715984564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2021-0149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.2217\/imt-2021-0149"],"URL":"https:\/\/doi.org\/10.2217\/imt-2021-0149","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}